Literature DB >> 10773944

Cell cycle control and cancer.

H P Wagner1.   

Abstract

This review consists of two parts. In the first part normal mechanisms regulating the progression of cells through the cell cycle are briefly reviewed. Besides mitogenic stimulation, cyclin kinase inhibition, the G1 restriction point and the prb pathway, accuracy of DNA replication and DNA repair, the G2 to M transition, apoptosis and the p 53 pathway, proteolytic, in particular ubiquitin-dependent mechanisms involved in the initiation of DNA synthesis in the separation of sister chromatids and in the telophase to GO/G1 transition, are discussed. In the second part oncogene and tumor suppressor gene products are briefly characterized. Aberrations of cell cycle control mechanisms associated with cancer are grouped as follows: deregulation of protooncogenes by translocations juxtaposing protooncogenes to immunoglobulin--or T cell receptor genes; translocations producing chimeric proteins unique to cancer cells; inversions and amplifications resulting in over expression of regulator genes; and deletions and mutations of tumor suppressor genes. It is emphasized that cancer is the result of a multistep process and that uncontrolled cell production and other alterations are, as a rule, late phenomena.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10773944     DOI: 10.1007/bf02831338

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  67 in total

1.  The expanding role of cell cycle regulators.

Authors:  T Jacks; R A Weinberg
Journal:  Science       Date:  1998-05-15       Impact factor: 47.728

Review 2.  Viewpoint: putting the cell cycle in order.

Authors:  K Nasmyth
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

Review 3.  Cell cycle checkpoints: preventing an identity crisis.

Authors:  S J Elledge
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

4.  A model for p53-induced apoptosis.

Authors:  K Polyak; Y Xia; J L Zweier; K W Kinzler; B Vogelstein
Journal:  Nature       Date:  1997-09-18       Impact factor: 49.962

5.  Inhibition of death receptor signals by cellular FLIP.

Authors:  M Irmler; M Thome; M Hahne; P Schneider; K Hofmann; V Steiner; J L Bodmer; M Schröter; K Burns; C Mattmann; D Rimoldi; L E French; J Tschopp
Journal:  Nature       Date:  1997-07-10       Impact factor: 49.962

6.  Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma.

Authors:  K M Kelly; R B Womer; P H Sorensen; Q B Xiong; F G Barr
Journal:  J Clin Oncol       Date:  1997-05       Impact factor: 44.544

Review 7.  Human papillomaviruses and associated malignancies.

Authors:  R M Alani; K Münger
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

8.  Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?

Authors:  A Zoubek; B Dockhorn-Dworniczak; O Delattre; H Christiansen; F Niggli; I Gatterer-Menz; T L Smith; H Jürgens; H Gadner; H Kovar
Journal:  J Clin Oncol       Date:  1996-04       Impact factor: 44.544

Review 9.  Role of the retinoblastoma protein in the pathogenesis of human cancer.

Authors:  W R Sellers; W G Kaelin
Journal:  J Clin Oncol       Date:  1997-11       Impact factor: 44.544

10.  A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3.

Authors:  P S White; J M Maris; C Beltinger; E Sulman; H N Marshall; M Fujimori; B A Kaufman; J A Biegel; C Allen; C Hilliard; M B Valentine; A T Look; H Enomoto; S Sakiyama; G M Brodeur
Journal:  Proc Natl Acad Sci U S A       Date:  1995-06-06       Impact factor: 11.205

View more
  1 in total

1.  Exploration of gene functions for esophageal squamous cell carcinoma using network-based guilt by association principle.

Authors:  Wei Wu; Bo Huang; Yan Yan; Zhi-Qiang Zhong
Journal:  Braz J Med Biol Res       Date:  2018-04-19       Impact factor: 2.590

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.